Mental Disorders (Overview) — Clinical Documentation Guide (2026)

This overview Clinical Documentation Guide covers the full spectrum of Mental and Behavioral Disorders (ICD-10-CM F01–F99) — the broadest diagnostic chapter in contemporary coding, encompassing conditions ranging from organic psychoses to childhood behavioral disorders. For coders, CDI specialists, and auditors, this guide provides the scaffolding for navigating the entire chapter while cross-referencing the dedicated CDGs for high-complexity subtopics.

Related CDGs: Anxiety Disorders | Depression (MDD) | Drug Dependence | Dementia

🔍 1. Definition

Mental and behavioral disorders are clinically significant conditions characterized by disturbances in cognition, emotion regulation, behavior, or neurobiological function that cause distress or impairment in personal, social, educational, or occupational functioning. The ICD-10-CM groups these disorders in Chapter 5 (F01–F99), spanning 10 major blocks from disorders due to known physiological conditions through childhood-onset behavioral disorders.

For clinical and coding purposes, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) published by the American Psychiatric Association provides the definitive clinical criteria. ICD-10-CM codes are the required reporting mechanism for billing and data submission in the United States under CMS guidelines.

The ICD-10-CM F chapter is organized into 10 major blocks:

• F01–F09: Mental disorders due to known physiological conditions (see Dementia CDG)
• F10–F19: Mental and behavioral disorders due to psychoactive substance use (see Drug Dependence CDG)
• F20–F29: Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
• F30–F39: Mood (affective) disorders
• F40–F48: Anxiety, dissociative, stress-related, somatoform and other non-psychotic disorders (see Anxiety CDG)
• F50–F59: Behavioral syndromes associated with physiological disturbances and physical factors
• F60–F69: Disorders of adult personality and behavior
• F70–F79: Intellectual disabilities
• F80–F89: Pervasive and specific developmental disorders
• F90–F98: Behavioral and emotional disorders with onset usually in childhood/adolescence
• F99: Mental disorder, not otherwise specified

🗂️ 2. Alternative Terminology

🩺 3. Signs & Symptoms

Signs and symptoms vary widely across the F chapter. Coders do not assign codes based solely on symptoms; a documented diagnosis by a treating provider is required per ICD-10-CM Official Guidelines Section IV (outpatient) and Section II (inpatient). The following broad categories serve as orientation:

Psychotic Spectrum (F20–F29)

• Positive symptoms: hallucinations (auditory most common), delusions, disorganized speech/thinking, catatonia
• Negative symptoms: flat affect, alogia, avolition, anhedonia, social withdrawal
• Cognitive symptoms: impaired working memory, executive dysfunction, attention deficits

Mood Disorders (F30–F39)

• Depressive episodes: depressed mood, anhedonia, weight/appetite changes, insomnia or hypersomnia, psychomotor agitation/retardation, fatigue, worthlessness/guilt, concentration difficulties, suicidal ideation
• Manic/hypomanic episodes: elevated or irritable mood, decreased need for sleep, grandiosity, pressured speech, flight of ideas, distractibility, increased goal-directed activity, risk-taking behavior
• Mixed features: simultaneous depressive and manic symptoms

Behavioral Syndromes (F50–F59)

• Eating disorders: refusal to maintain weight, binge-purge cycles, excessive restriction, distorted body image, medical sequelae (electrolyte abnormalities, arrhythmias, bone density loss)
• Sleep disorders: difficulty initiating/maintaining sleep, non-restorative sleep, excessive daytime sleepiness, parasomnias

Developmental & Childhood Onset (F70–F98)

• Intellectual disability: deficits in intellectual functioning (IQ <70) and adaptive functioning across conceptual, social, and practical domains
• ASD: social communication deficits, restricted/repetitive behaviors, sensory sensitivities
• ADHD: inattention, hyperactivity, impulsivity persisting >6 months in ≥2 settings, onset before age 12

🧭 4. Differential Diagnosis

📋 5. Clinical Indicators for Coders/CDI

The following clinical indicators support accurate and specific code assignment across the mental disorders chapter. CDI specialists should review records for these elements to query when missing or unclear.

🦴 6. Anatomy & Pathophysiology

Mental disorders involve complex neurobiological, genetic, and environmental interactions. This section provides a high-level overview relevant to coding documentation — understanding pathophysiology supports recognition of appropriate clinical indicators in documentation.

Neurobiological Foundations

Major mental disorders involve dysregulation of key neurotransmitter systems (NIMH):

• Dopaminergic pathways: Mesolimbic hyperdopaminergia underlies positive psychotic symptoms (schizophrenia, mania); mesocortical hypodopaminergia contributes to negative/cognitive symptoms. Dopamine dysregulation is central to reward processing in addiction (F10–F19) and ADHD (F90).
• Serotonergic system: 5-HT dysregulation is implicated in depression (F32–F33), anxiety (F40–F48), eating disorders (F50), and OCD (F42). SSRIs/SNRIs modulate this system.
• Noradrenergic system: Norepinephrine dysregulation contributes to depression, PTSD (F43.10), and ADHD. SNRIs and TCAs act on this system.
• GABAergic/Glutamatergic systems: GABA hypofunction and glutamate (NMDA) receptor hypofunction are implicated in schizophrenia pathophysiology. Benzodiazepines target GABA-A receptors for anxiety.

Brain Structures Implicated

• Prefrontal cortex: Executive function, impulse control; hypoactive in schizophrenia negative symptoms, ADHD, borderline PD
• Amygdala: Threat response, emotional memory; hyperactive in PTSD, anxiety disorders, borderline PD
• Hippocampus: Memory consolidation; reduced volume in MDD (stress-mediated neurodegeneration), PTSD, schizophrenia
• Anterior cingulate cortex: Error monitoring, emotional regulation; implicated in OCD, depression, ADHD
• Basal ganglia: Habit/reward circuits; implicated in OCD, tic disorders (F95), substance use (F10–F19)

Genetic and Environmental Contributions

Most major mental disorders are polygenic with heritability estimates: schizophrenia ~80%, bipolar disorder ~75–85%, MDD ~37–50%, ADHD ~70–80% (Nature Molecular Psychiatry). Environmental risk factors include childhood adversity, prenatal stress/infection, substance exposure, and psychosocial stressors — captured in coding via Z55–Z65 codes.

💊 7. Medication Impact / Treatment

Pharmacotherapy is a mainstay across most mental disorder categories. Medication documentation in the medical record supports clinical necessity, confirms diagnoses, and is critical for long-term drug therapy coding (Z79.899).

Antipsychotics (F20–F29, F30–F39 with psychosis)

• First-generation (typical) antipsychotics: Haloperidol, fluphenazine, chlorpromazine — D2 antagonists; risk of EPS requiring benztropine (J0515)
• Second-generation (atypical) antipsychotics: Olanzapine (Zyprexa Relprevv IM J2358), risperidone, quetiapine, aripiprazole, clozapine (requires ANC monitoring), lurasidone, ziprasidone
• Long-acting injectable (LAI) antipsychotics: Paliperidone palmitate (Invega Sustenna/Trinza J2426), haloperidol decanoate — improve adherence, require specific HCPCS J-code billing

Mood Stabilizers (F30–F39)

• Lithium — first-line for bipolar disorder; narrow therapeutic window; renal/thyroid monitoring required
• Valproate (divalproex sodium) — mood stabilization; anticonvulsant; teratogenic (document for pregnancy risk)
• Lamotrigine — bipolar depression; Stevens-Johnson syndrome risk; slow titration
• Carbamazepine/oxcarbazepine — bipolar maintenance; CYP450 interactions

Antidepressants (F32–F39, F40–F48)

• SSRIs: fluoxetine, sertraline, escitalopram, paroxetine, fluvoxamine, citalopram
• SNRIs: venlafaxine, duloxetine, desvenlafaxine
• Bupropion (NDRI): MDD; also for smoking cessation (Z87.891)
• TCAs: nortriptyline, amitriptyline — generally second-line due to cardiac risk/overdose danger
• MAOIs: phenelzine, tranylcypromine — third-line; dietary restrictions; serotonin syndrome risk

ADHD Medications (F90)

• Stimulants: methylphenidate, amphetamine salts (Adderall), lisdexamfetamine (Vyvanse)
• Non-stimulants: atomoxetine, guanfacine, clonidine
• Document controlled substance prescribing, PDMP compliance, and any diversion concerns

Z Code for Medication Documentation

Z79.899 (Other long-term (current) drug therapy) is reported when a patient is on chronic psychiatric medication such as antipsychotics, lithium, or antidepressants for an established psychiatric condition. This code supports medical necessity documentation in risk-based contracts.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 8. ICD-10-CM Guidelines (FY2026)

The following guidelines from the FY2026 ICD-10-CM Official Guidelines for Coding and Reporting govern assignment of F-chapter codes:

General Mental Disorders Guidelines

• Provider diagnosis required: Mental disorder codes must be based on provider documentation of the diagnosis, not assignment by the coder from symptoms alone (Section II.B and Section IV.A).
• Inpatient “uncertain” diagnoses: For inpatient admissions, conditions documented as “probable,” “suspected,” “likely,” or “questionable” may be coded as if confirmed at discharge (Section II.H). This is critical for capturing psychiatric diagnoses established during inpatient psychiatric stays.
• Outpatient coding: Do NOT code probable/suspected diagnoses outpatient — code the sign or symptom (Section IV.H). Exception: in an established outpatient setting where the diagnosis is the reason for the encounter, document the confirmed diagnosis.
• Sequencing: When a mental disorder is the principal diagnosis driving an inpatient admission, sequence the F-code first. When a mental disorder complicates a medical admission (e.g., MDD affecting management of DM), sequence as an additional diagnosis.

Psychoactive Substance Disorders (F10–F19)

• Use additional code for blood alcohol level (Y90.x) when clinically relevant
• Distinguish use vs. abuse vs. dependence — these are not interchangeable; dependence codes to a higher level of specificity
• When both use and a substance-induced condition are present (e.g., alcohol dependence with alcohol-induced psychotic disorder), use combination codes F1x.x59 (or specific 4th/5th character codes)
• See Drug Dependence CDG for detailed guidance

Mood Disorders — Key Coding Principles

• F32.A Depression, unspecified (NEW FY2023, carried forward FY2026): This code was created for use when “depression NOS” or “depression unspecified” is documented and the provider cannot further specify. However, F32.A does NOT map to HCC in most MA models — query for severity when clinically documented evidence supports it.
• F32.81 Premenstrual dysphoric disorder (PMDD): Requires documentation of cyclical relationship to menstrual cycle; code in addition to any F33.x if concurrent recurrent MDD exists.
• F34.81 Disruptive mood dysregulation disorder (DMDD): Pediatric diagnosis (ages 6–18 per DSM-5); requires documentation of chronic irritability, frequent severe temper outbursts. Do not code with F90.x ADHD as a duplicate if DMDD is the primary condition.

Autism Spectrum Disorder (F84.0)

• When ASD is documented with intellectual disability, assign codes for both: F84.0 and the appropriate F7x code
• Document level of support required per DSM-5 (Level 1, 2, or 3) — though not captured in ICD-10-CM directly, supports medical necessity
• Asperger syndrome (F84.5) is retained in ICD-10-CM but DSM-5 now subsumes it under F84.0 ASD; document clinical rationale if F84.5 is used

Eating Disorders (F50)

• Code the specific type: restricting (F50.01) vs. binge-eating/purging type (F50.02) for anorexia — the subtype matters for HCC mapping (both → HCC 48)
• ARFID (F50.82) — avoidant/restrictive food intake disorder; a distinct entity from anorexia; does not require body image disturbance
• Code sequelae separately (e.g., hypokalemia E87.6, malnutrition E43, cardiac arrhythmia) when clinically documented

FY2026 New/Revised Codes (Chapter 5 Highlights)

Verify against the CMS FY2026 ICD-10-CM tabular addenda for all additions and revisions effective October 1, 2025. Notable recent additions in prior cycles retained in FY2026:

• F32.A — Depression, unspecified (added FY2023)
• F32.81 — Premenstrual dysphoric disorder (added FY2022)
• F34.81 — Disruptive mood dysregulation disorder (added FY2021)
• F50.82 — Avoidant/restrictive food intake disorder (ARFID; added FY2021)
• F32.0–F32.4, F32.89 — MDD single episode subcategory expansion (FY2021)

🔢 9. ICD-10-CM Code Set (FY2026)

F01–F09: Mental Disorders Due to Known Physiological Conditions

See Dementia CDG for detailed coverage of F01–F09 codes including vascular dementia (F01.xx), Alzheimer’s dementia (F02.xx), and delirium (F05).

F10–F19: Mental/Behavioral Disorders Due to Psychoactive Substance Use

See Drug Dependence CDG for detailed coverage of F10–F19 codes including opioid use disorder, alcohol use disorder, and substance-induced conditions.

F20–F29: Schizophrenia Spectrum and Other Psychotic Disorders

F30–F39: Mood (Affective) Disorders

F40–F48: Anxiety, Dissociative, Stress-Related, Somatoform Disorders

See Anxiety CDG for detailed coverage. Summary of key codes:

F50–F59: Behavioral Syndromes

F60–F69: Personality and Behavior Disorders of Adults

F70–F79: Intellectual Disabilities

F80–F89: Developmental Disorders

F90–F98: Behavioral/Emotional Disorders Onset Childhood/Adolescence

Related Z Codes

🔎 10. Indexing

The FY2026 ICD-10-CM Alphabetic Index provides multiple pathways to mental disorder codes. Key index terms:

Indexing pitfall: “Psychotic depression” indexes to F32.3 (single episode) or F33.3 (recurrent) depending on episode pattern. “Depression with psychotic features” is the preferred documentation term for coding accuracy.

🏥 11. CPT (2026)

The following CPT 2026 codes are used for psychiatric evaluation, psychotherapy, and related services. Note that psychiatric services have specific rules for time-based reporting and add-on code usage.

🧾 12. HCPCS (2026)

📚 13. AHA Coding Clinic (Recent Guidance)

The AHA Coding Clinic for ICD-10-CM/PCS is the official publication for ICD-10 coding guidance. Relevant guidance for mental disorders includes:

💰 14. HCC / Risk Adjustment (v28)

Under the CMS-HCC Model v28 (phased in beginning CY2024, fully effective CY2026), mental health HCC assignments have been restructured. The following mapping reflects the v28 model.

✍️ 15. CDI Query Templates

All queries below comply with ACDIS and AHIMA query format standards: non-leading, multiple-choice format with a “clinically unable to determine” option, based on clinical indicators present in the record.

🧑‍⚕️ 16. Treatments (Clinical)

Evidence-Based Psychotherapies

The following psychotherapies have level A or B evidence for specific mental disorder categories per APA Practice Guidelines:

• Cognitive Behavioral Therapy (CBT): First-line for MDD, anxiety disorders, PTSD, OCD, eating disorders, and insomnia (CBT-I)
• Dialectical Behavior Therapy (DBT): Evidence-based for borderline personality disorder; also used for treatment-resistant depression, eating disorders, and PTSD
• Prolonged Exposure (PE) and EMDR: First-line for PTSD (F43.10–F43.12)
• Interpersonal Therapy (IPT): Evidence-based for MDD, particularly perinatal depression (F53.0)
• Applied Behavior Analysis (ABA): Supported intervention for ASD (F84.0); coverage varies by payer
• Parent-Child Interaction Therapy (PCIT): For conduct disorders (F91.x) and ODD (F91.3) in children ages 2–7

Somatic Treatments

• Electroconvulsive Therapy (ECT — CPT 90870): Indicated for severe TRD, bipolar disorder with severe manic or depressive episodes, catatonia (F20.2), and psychotic depression; document medical necessity, anesthesia consent, and seizure documentation
• Transcranial Magnetic Stimulation (TMS — CPT 90867–90869): FDA-cleared for MDD, OCD, and anxious depression; requires documentation of 4+ failed adequate antidepressant trials; prior authorization from most payers
• Ketamine/Esketamine (Spravato — REMS): For treatment-resistant depression; administered in certified healthcare settings; document TRD criteria (2+ failed adequate antidepressant trials)

Psychiatric Inpatient / Levels of Care

• Inpatient psychiatric hospitalization: For imminent suicidal/homicidal risk, acute psychosis, severe manic episode, or medical instability due to eating disorder. MS-DRG 880–887 apply based on diagnosis and comorbidities.
• Partial hospitalization program (PHP): Step-down from inpatient; 20+ hours/week structured treatment; CPT 99213–99215 or facility-specific codes; document diagnosis, functional impairment, and treatment goals
• Intensive outpatient program (IOP): 9–19 hours/week; HCPCS H0015 (substance abuse IOP) or H2019 (mental health IOP — Medicaid)

🎓 17. Patient Education / Summary

For Patients and Families

Mental health conditions are medical conditions — not personal weaknesses or character flaws. They involve changes in brain chemistry, structure, and function that respond to treatment just as other medical conditions do. The following key points support patient and family understanding:

• Diagnosis matters: Getting a specific diagnosis helps your care team recommend the most effective treatments. Different types of depression, for example, respond to different treatments.
• Treatment works: The large majority of people with mental health conditions, including schizophrenia, bipolar disorder, and depression, experience significant improvement with appropriate treatment according to NIMH research.
• Recovery is possible: Recovery does not always mean the absence of symptoms — it means living a meaningful, satisfying life while managing one’s condition.
• You can help your coding team: When your provider asks about the severity of your depression or whether you have had manic episodes, these questions help ensure you get the right diagnosis documented — which affects your insurance coverage, care coordination, and access to specialized programs.

Key Organizations for Patients

• NAMI (National Alliance on Mental Illness) — advocacy, support groups, family education programs
• SAMHSA (Substance Abuse and Mental Health Services Administration) — treatment locator, crisis line (988)
• NIMH (National Institute of Mental Health) — evidence-based information on all mental health conditions
• Depression and Bipolar Support Alliance (DBSA) — peer support for mood disorders

Crisis Resources

988 Suicide and Crisis Lifeline: Call or text 988 (US). Available 24/7. For immediate psychiatric emergencies, call 911 or go to the nearest emergency department. SAMHSA 988 Lifeline.

Summary for Coders and CDI Specialists

The mental and behavioral disorders chapter (F01–F99) is one of the highest-risk chapters for coding specificity in risk-adjusted populations. The primary CDI opportunities are:

1. MDD severity: Never default to F32.9 or F33.9 when clinical documentation supports a specific severity level
2. Bipolar episode type: Document and code the current episode type, not just “bipolar disorder”
3. Eating disorder subtype: Anorexia restricting vs. purging matters for both clinical management and HCC
4. Personality disorder type: BPD (F60.3) maps to HCC 152; unspecified (F60.9) does not
5. Annual recapture: Chronic psychiatric conditions must be documented in a face-to-face encounter in the measurement year to receive HCC credit — status diagnoses on problem lists are insufficient without active documentation

For detailed guidance on specific subtopics, refer to the companion CDGs: Anxiety Disorders, Depression (MDD), Drug Dependence, and Dementia.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)